loader from loading.io

Life After Diagnosis: Thriving Beyond Treatment - Breast Cancer Awareness Panel

MD Newsline

Release Date: 02/10/2026

Late-Stage Breast Cancer Diagnosis Among Black Women in the Mid-South show art Late-Stage Breast Cancer Diagnosis Among Black Women in the Mid-South

MD Newsline

In this episode of MD Newsline, Dr. Janeane N. Anderson, Assistant Professor at the University of Tennessee Health Science Center and breast cancer researcher, shares insights from the ACCESS Study—an innovative qualitative research initiative focused on understanding why Black women in the Mid-South region are disproportionately diagnosed with advanced-stage breast cancer. Dr. Anderson discusses structural barriers, community-based recruitment strategies, and the importance of centering lived experiences in oncology research. She also highlights the critical need for equitable research...

info_outline
Understanding Cancer Disparities, Mistrust, and Access to Care show art Understanding Cancer Disparities, Mistrust, and Access to Care

MD Newsline

In this episode of MD Newsline, Dr. Jordonna Brown, a medical oncologist at Kings County Hospital in New York City, shares her frontline experience caring for patients in a safety-net hospital setting. Speaking from the San Antonio Breast Cancer Symposium (SABCS), Dr. Brown discusses cancer disparities, late-stage presentation, mistrust in the healthcare system, and the evolving landscape of breast cancer treatment. She offers a candid look at the social determinants of health shaping patient outcomes—from delayed screening and misconceptions about chemotherapy to barriers in long-term...

info_outline
Inflammation and Resistance in MDS & AML: Targeting the JAK-STAT Axis show art Inflammation and Resistance in MDS & AML: Targeting the JAK-STAT Axis

MD Newsline

In this episode of MD Newsline, Dr. Theodoros Karantanos, Assistant Professor of Medical Oncology at the Johns Hopkins University Sidney Kimmel Cancer Center, discusses the emerging role of inflammatory signaling in high-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Dr. Karantanos shares insights from his laboratory research exploring how inflammatory pathways—particularly interferon gamma and JAK-STAT signaling—contribute to treatment resistance, including resistance to venetoclax. He also highlights the impact of TP53 mutations, bone marrow microenvironment...

info_outline
Host Factors in Immunotherapy: How Sex, Aging, and Lifestyle Shape Cancer Outcomes show art Host Factors in Immunotherapy: How Sex, Aging, and Lifestyle Shape Cancer Outcomes

MD Newsline

In this episode of MD Newsline, Dr. Marco Ruella, Associate Professor of Medicine at the University of Pennsylvania and Scientific Director of the Lymphoma Program, joins us from the American Society of Hematology (ASH) meeting to discuss a paradigm-shifting topic: host factors in cancer immunotherapy. Dr. Ruella explores how biological sex, aging, chronic inflammation, obesity, exercise, and the microbiome influence responses to therapies such as checkpoint inhibitors and CAR T-cell therapy. The conversation highlights emerging data, translational research, and the growing need to...

info_outline
What’s Next for CAR-T Cells? In Vivo Design, Toxicity, and Persistence show art What’s Next for CAR-T Cells? In Vivo Design, Toxicity, and Persistence

MD Newsline

In this episode of MD Newsline,  Dr. Dejah Blake, a fifth-year PhD candidate at Emory University, joins us from the American Society of Hematology (ASH) conference to discuss the rapidly evolving landscape of CAR T-cell therapy. Dejah shares insights into engineering next-generation CAR T cells, improving accessibility through in vivo manufacturing, and addressing diversity gaps in clinical research. From armored CARs to gene editing and humanized mouse models, this conversation explores how innovation and equity must move forward together in advancing cancer immunotherapy. Episode...

info_outline
The Psychology of Prevention: Behavioral Strategies for Better Health Outcomes show art The Psychology of Prevention: Behavioral Strategies for Better Health Outcomes

MD Newsline

In this episode of MD Newsline, behavioral scientist  Dr. Josh Klapow, registered dietitian Kim Shapira, and health advocate Sishman Rimpson explore the powerful connection between psychology, nutrition, and long-term health outcomes. Together, they unpack how behavioral patterns, mindset, and sustainable lifestyle changes influence chronic disease prevention and patient adherence. The discussion highlights the real-world challenges patients face when attempting to modify diet, physical activity, and stress management—and how healthcare professionals can better support lasting change...

info_outline
Beyond Statins: Modern Cholesterol Care, Risk Assessment, and the Future of Lipid Therapy show art Beyond Statins: Modern Cholesterol Care, Risk Assessment, and the Future of Lipid Therapy

MD Newsline

In this episode of MD Newsline, Dr. Amber Johnson, Assistant Professor of Medicine and General Cardiologist at the University of Chicago, provides an in-depth look at modern cholesterol management and cardiovascular risk reduction. She discusses evolving lipid guidelines, aggressive LDL-C targets, statin intolerance, and the growing role of non-statin therapies. Dr. Johnson also explores emerging research on lipoprotein(a), hypertriglyceridemia, and future directions in lipid-lowering treatment. Episode Highlights Evolving Cholesterol Management and ASCVD Risk Dr. Johnson explains how...

info_outline
Man Enough to Feel: Breaking the Stigma Around Men’s Mental Health show art Man Enough to Feel: Breaking the Stigma Around Men’s Mental Health

MD Newsline

In this episode of MD Newsline, a distinguished panel of physicians, mental health leaders, former professional athletes, and performance coaches come together for a powerful discussion on men’s mental health, vulnerability, and emotional wellbeing. The conversation explores how traditional definitions of masculinity impact mental health, performance, relationships, and help-seeking behaviors—and why redefining strength is critical for future generations. Panelists include Dr. Mike Banna, Dominique Easley, Jason Sousa, Dr. Nate Evans Jr., and Dr. Pete Thomas, each bringing unique...

info_outline
Understanding Alzheimer’s Disease: Biomarkers and Early Detection show art Understanding Alzheimer’s Disease: Biomarkers and Early Detection

MD Newsline

In this episode of MD Newsline, Dr. Rudolph J. Castellani, a neuropathologist and Director of the Division of Neuropathology at Northwestern University, offers a deep dive into the biology, diagnosis, and ongoing controversies surrounding Alzheimer’s disease. He explores how Alzheimer’s is defined clinically and pathologically, the evolving role of biomarkers in early detection, and why modifying biomarkers has not yet translated into meaningful clinical improvement for patients. Dr. Castellani also discusses the promise and limitations of artificial intelligence, personalized medicine,...

info_outline
From Hormones to Longevity: A Modern Approach to Men’s Health show art From Hormones to Longevity: A Modern Approach to Men’s Health

MD Newsline

In this episode of MD Newsline, a panel of men’s health experts—Dr. Tracy Gapin, Dr. Joseph Acquaye, and Justin Birckbichler—come together to discuss a modern, proactive approach to men’s health. The conversation explores the importance of prevention, hormone optimization, cardiovascular risk, and lifestyle-driven strategies to improve long-term health outcomes for men. The panel addresses common gaps in men’s healthcare, including delayed screenings, lack of awareness around hormone health, and the cultural barriers that prevent men from seeking early medical intervention. Drawing...

info_outline
 
More Episodes

In this special panel episode of MD Newsline, recorded during Breast Cancer Awareness Month, a multidisciplinary group of experts and advocates explores the often-overlooked realities of breast cancer survivorship. Clinical psychologist and breast cancer survivor Dr. Christina Hibbert, breast and gynecologic medical oncologist Dr. Eleonora Teplinsky, and patient advocate and survivor Aisha Patterson share candid insights into the mental, emotional, social, and financial challenges that persist long after active treatment ends.

Through both clinical perspectives and lived experiences, the panel highlights why survivorship is not an endpoint—but a lifelong phase requiring personalized, integrated support. 

Episode Highlights

The Mental and Emotional Impact of Breast Cancer
The panel discusses how breast cancer diagnosis and treatment are inherently traumatic experiences. Anxiety, depression, and PTSD are common among survivors, particularly after treatment concludes, when support often fades. Dr. Hibbert emphasizes that survivorship can feel more difficult than active treatment and calls for mental health care to be integrated from diagnosis onward.

Life After Treatment: Survivorship Is Forever
Survivors share how ringing the bell does not mark a return to “normal.” Lingering fatigue, chronic illness, fear of recurrence, and identity changes shape daily life. The panel reframes survivorship as an ongoing journey rather than a finish line.

Financial Toxicity and Access to Care
The discussion highlights how financial stress—from insurance gaps, treatment costs, lost income, and uncovered supportive therapies—directly impacts mental health and treatment adherence. Dr. Teplinsky explains how financial toxicity screenings and advocacy resources can help identify patients in need, while Aisha shares practical guidance on accessing grants and support programs.

The Role of Community and Peer Support
Social media and survivor communities play a vital role in helping patients feel seen and understood. Panelists discuss how peer networks often fill critical gaps left by traditional healthcare systems, especially for younger survivors navigating body image changes, early menopause, and long-term side effects.

Caregiver and Family Support
The episode underscores the emotional toll cancer takes on caregivers, partners, and children. The panel calls for better inclusion of caregivers in care planning, validation of caregiver burnout, and access to mental health resources for families affected by cancer.

Redefining Thriving After Cancer
Thriving looks different for every survivor. From redefining purpose and setting boundaries to honoring rest and self-care, the panel encourages patients and providers alike to embrace individualized definitions of healing and quality of life.

Key Takeaway

Breast cancer care must extend beyond physical treatment to address mental health, financial strain, relationships, and long-term survivorship needs. By normalizing emotional struggles, supporting caregivers, and connecting patients to meaningful resources, healthcare teams can help survivors feel less alone and more empowered throughout their journey.

Resources

MD Newsline
Website:
https://mdnewsline.com/
Newsletter:
https://mdnewsline.com/subscribe/

Connect with the Panelists

·        Aisha Patterson: Here

·        Dr. Christina Hibbert: https://drchristinahibbert.com/

·        Dr. Eleonora Teplinsky: Here